The diagnostic usefulness of 11C-methionine PET scans in gliomas is still controversial. The authors investigated the clinical significance of 11C-methionine PET findings in preoperative diagnosis of histological type and grade.
The tissue uptake of 11C-methionine was assessed using PET in 70 patients with histologically confirmed intracerebral gliomas. The ratio of maximum standard uptake values in tumor areas to the mean standard uptake values in the contralateral normal brain tissue (tumor/normal tissue [T/N] ratio) was calculated and correlated with tumor type, histological grade, contrast enhancement on MR imaging, Ki 67 labeling index, and 1p/19q status.
The T/N ratio was significantly increased as tumor grade advanced in astrocytic tumors (WHO Grade II vs Grade III, p = 0.0011; Grade III vs Grade IV, p = 0.0007). Among Grade II gliomas, the mean T/N ratio was significantly higher in oligodendroglial tumors than in diffuse astrocytomas (DAs) (p < 0.0001). All T/N ratios for oligodendroglial tumors were ≥ 1.46, and those for DA were consistently < 1.46, with the exception of 2 cases of gemistocytic astrocytoma. The Ki 67 labeling index significantly correlated with T/N ratio in astrocytic tumors, but not in oligodendrogliomas. Oligodendroglial tumors without 1p/19q deletion had a significantly higher T/N ratio than those with the codeletion. In combination with Gd-enhanced MR imaging, 67% of nonenhanced tumors with a T/N ratio of ≥ 1.46 were proved to be Grade II oligodendrogliomas.
These results clearly show that 11C-methionine PET T/N ratios in Grade II oligodendrogliomas were higher than those in DAs independently of their proliferative activity. This information contributes to preoperative differential diagnoses of histological type, especially in suspected low-grade gliomas.
Abbreviations used in this paper: DA = diffuse astrocytoma; FISH = fluorescence in situ hybridization; LI = labeling index; ROI = region of interest; SUV = standard uptake value; T/N = tumor/normal tissue.
Address correspondence to: Yasuo Iwadate, M.D., Ph.D., Department of Neurological Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba 260-8670, Japan. email: email@example.com.
Please include this information when citing this paper: published online January 7, 2011; DOI: 10.3171/2010.11.JNS10553.
BraunVDempfSWellerRReskeSNSchachenmayrWRichterHP: Cranial neuronavigation with direct integration of (11)C methionine positron emission tomography (PET) data—results of a pilot study in 32 surgical cases. Acta Neurochir (Wien)144:777–7822002
GianniniCBurgerPCBerkeyBACairncrossJGJenkinsRBMehtaM: Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol18:360–3692008
GoldmanSLevivierMPirotteBBrucherJMWiklerDDamhautP: Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer78:1098–11061996
KatoTShinodaJNakayamaNMiwaKOkumuraAYanoH: Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol29:1176–11822008
KrachtLWFrieseMHerholzKSchroederRBauerBJacobsA: Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging30:868–8732003
KrachtLWMileticHBuschSJacobsAHVogesJHoevelsM: Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res10:7163–71702004
NariaiTTanakaYWakimotoHAoyagiMTamakiMIshiwataK: Usefulness of L-[methyl-11C] methionine–positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg103:498–5072005
OkitaYKinoshitaMGotoTKagawaNKishimaHShimosegawaE: (11)C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: a stereotactic image-histology comparison. Neuroimage49:2977–29822010